VWM
UTHR icon

Venturi Wealth Management’s United Therapeutics UTHR Stock Holding History

Venturi Wealth Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-368
Closed -$218K – 686
2026
Q1 		$218K Buy
+368
New +$183K 0.01% 552
2025
Q1 		– Sell
-385
Closed -$136K – 1773
2024
Q4 		$136K Buy
+385
New +$142K 0.01% 656

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Venturi Wealth Management's UTHR Position: Q2 2026 in Review

Venturi Wealth Management sold out of United Therapeutics (UTHR) in Q2 2026, closing a stake of 368 shares — an estimated $218K sold.

Venturi Wealth Management first reported a position in UTHR in Q4 2024 and held it in 2 quarters. The position peaked at $218K in Q1 2026. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Venturi Wealth Management reported no remaining United Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Venturi Wealth Management sold 368 United Therapeutics shares in Q2 2026, an estimated $218K.
  • Venturi Wealth Management first reported a position in United Therapeutics in Q4 2024 and held it in 2 quarters.
  • Venturi Wealth Management's United Therapeutics position peaked at $218K in Q1 2026.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Venturi Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.